Metagenomic Changes of Gut Microbiota following Treatment of Helicobacter pylori Infection with a Simplified Low-Dose Quadruple Therapy with Bismuth or Lactobacillus reuteri.

Background: Probiotic supplementation to antibiotic regimens against Helicobacter pylori infection has been proposed to improve eradication rate and to decrease detrimental effects on gut microbiota. Aims: To evaluate microbiota modifications due to a low-dose quadruple therapy with bismuth or Lacto...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrients Vol. 14; no. 14
Autores principales: Dore, Maria Pina, Sau, Rosangela, Niolu, Caterina, Abbondio, Marcello, Tanca, Alessandro, Bibbò, Stefano, Loria, Mariafrancesca, Pes, Giovanni Mario, Uzzau, Sergio
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: MDPI Jul2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158298434&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 158298434
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726643
        B0TT
      jtl: Nutrients
      issn: 20726643
      maglogo: N
    pubinfo:
      dt: Jul2022
      vid: 14
      iid: 14
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        158298434
        158298434
        158298434
        10.3390/nu14142789
        158298434
      ppct: 12
      formats:
      tig:
        atl: Metagenomic Changes of Gut Microbiota following Treatment of Helicobacter pylori Infection with a Simplified Low-Dose Quadruple Therapy with Bismuth or Lactobacillus reuteri.
      aug:
        au:
          Dore, Maria Pina
          Sau, Rosangela
          Niolu, Caterina
          Abbondio, Marcello
          Tanca, Alessandro
          Bibbò, Stefano
          Loria, Mariafrancesca
          Pes, Giovanni Mario
          Uzzau, Sergio
        affil: Dipartimento di Medicina, Chirurgia e Farmacia, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy
      sug:
        subj:
          Gut Microbiota Analysis
          Helicobacter Infections Therapy
          Bismuth Administration and Dosage
          Lactobacillus
          Drug Efficacy
          Probiotics Adverse Effects
          Bismuth Adverse Effects
          Genomics
          Human
          Prospective Studies
          Randomized Controlled Trials
          Random Assignment
          Sequence Analysis
          Rabeprazole Sodium Administration and Dosage
          Tetracycline Administration and Dosage
          Metronidazole Administration and Dosage
          Antibiotics
          Feces
          Data Analysis Software
          Questionnaires
          Medication Compliance
          Confidence Intervals
          Descriptive Statistics
          Multivariate Analysis of Variance
          Male
          Female
          Middle Age
          Aged
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Background: Probiotic supplementation to antibiotic regimens against Helicobacter pylori infection has been proposed to improve eradication rate and to decrease detrimental effects on gut microbiota. Aims: To evaluate microbiota modifications due to a low-dose quadruple therapy with bismuth or Lactobacillus reuteri. Methods: Forty-six patients infected with H. pylori were prospectively enrolled in a single-centre, randomized controlled trial to receive b.i.d. with meals for 10 days low-dose quadruple therapy consisting of rabeprazole 20 mg and bismuth (two capsules of Pylera® plus 250 mg each of tetracycline and metronidazole), or the same dose of rabeprazole and antibiotics plus Gastrus® (L. reuteri), one tablet twice-a-day for 27 days. Stool samples were collected at the enrolment, at the end and 30–40 days after the treatment. Gut microbiota composition was investigated with 16S rRNA gene sequencing. Results: Eradication rate was by ITT 78% in both groups, and by PP analysis 85.7% and 95.5% for Gastrus® and bismuth group, respectively. Alpha and beta diversity decreased at the end of treatment and was associated with a reduction of bacterial genera beneficial for gut homeostasis, which was rescued 30–40 days later in both groups, suggesting a similar impact of the two regimens in challenging bacterial community complexity. Conclusions: Low-dose bismuth quadruple therapy proved to be effective with lower costs and amount of antibiotics and bismuth. Gastrus® might be an option for patients with contraindications to bismuth. L. reuteri was unable to significantly counteract dysbiosis induced by antibiotics. How to administer probiotics to prevent gut microbiota alterations remains an open question.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N